Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic PreparednessWorld-leading virologists highlight advances in antiviral therapeutics, artificial intelligence, immunology, and global surveillance shaping how future pandemics may be detected and controlled
HCM IV Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 6, 2026Norwalk, CT, April 02, 2026 (GLOBE NEWSWIRE) -- HCM IV Acquisition Corp. (
NASDAQ: HACQU) (the “Company”) announced today that, commencing April 6, 2026, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols “HACQ” and “HACQW,” respectively. Those units not separated will continue to trade on the Nasdaq under the symbol “HACQU.”
Delinea Appoints Scott Goree as SVP of Channel and Alliances to Lead Next Phase of Partner-Led GrowthGlobal channel leader to scale partner ecosystem and help customers adopt modern identity security for the AI era
Cumulus Media's Westwood One Presents Exclusive Full-Court Audio Coverage of the 2026 NCAA® Division I Men's and Women's Basketball Final Four® and National Championship Games on Multiple PlatformsWestwood One’s Final Four Coverage Connects College Hoops Fans across Multiple Platforms – 500+ Radio Stations, SiriusXM, NCAA March Madness Live™; via Free Online Streaming at WestwoodOneSports.com and the Westwood One Sports App, The Varsity Network App & on Alexa-Enabled Devices; also Available with TuneIn Premium
SMCI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Super Micro (SMCI) Investors of Securities Class Action Deadline on May 26, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Super Micro To Contact Him Directly To Discuss Their Options
IT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gartner (IT) Investors of Securities Class Action Deadline on May 18, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gartner To Contact Him Directly To Discuss Their Options
Guggenheim Investments Announces Final Close of Guggenheim Private Debt Fund IV at ~$8.4 Billion of Total Available CapitalNEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments announced the final close of Guggenheim Private Debt Fund IV (“PDF IV” or the “Fund”), its most recent dedicated private debt vehicle. The Fund and related vehicles raised approximately $8.4 billion of total available capital, exceeding the initial fundraise target and with demand exceeding the Fund’s hard cap*.
RR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Richtech To Contact Him Directly To Discuss Their Options
RARE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their Options
ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. - IBRXNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against ImmunityBio, Inc. (NasdaqGS: IBRX) (“ImmunityBio” or the “Company”), if they purchased or otherwise acquired the Company’s securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
GEMI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Gemini Space Station (GEMI) Investors of Securities Class Action Deadline on May 18, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gemini To Contact Him Directly To Discuss Their Options
Super Micro Computer Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Super Micro Computer, Inc. - SMCINEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NasdaqGS: SMCI), if they purchased or otherwise acquired the Company’s securities between April 30, 2024 and March 19, 2026, (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UniQure To Contact Him Directly To Discuss Their Options
Trip.com Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Trip.com Group Limited - TCOMNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 11, 2026 to file lead plaintiff applications in a securities class action lawsuit against Trip.com Group Limited (NasdaqGS: TCOM) (“Trip.com” or the “Company”), if they purchased or otherwise acquired the Company’s securities between April 30, 2024 and January 13, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
TCOM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Trip.com Group (TCOM) Investors of Securities Class Action Deadline on May 11, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Trip.com To Contact Him Directly To Discuss Their Options
HUBG SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub GroupFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options
Gemini Space Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gemini Space Station, Inc. - GEMINEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 18, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gemini Space Station, Inc. (“Gemini” or the “Company”) (NasdaqGS: GEMI), if they purchased or otherwise acquired Gemini Class A common stock pursuant and/or traceable to the Company’s September 12, 2025 initial public offering (“IPO”), and/or Gemini securities between September 12, 2025 and February 17, 2026 (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
AQST SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aquestive To Contact Him Directly To Discuss Their Options
Driven Brands Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Driven Brands Holdings Inc. - DRVNNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 8, 2026 to file lead plaintiff applications in a securities class action lawsuit against Driven Brands Holdings Inc. (NasdaqGS: DRVN) (“Driven” or the “Company”), if they purchased or otherwise acquired the Company’s shares between May 9, 2023 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
NCLA Wins Deletion of Data from Covid Spyware Massachusetts Auto-Installed on > 1 Million PhonesRobert Wright, et al. v. Robert Goldstein, in his official capacity as Comm’r of the Mass. Dept. of Public Health
FBRT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Franklin BSP Realty Trust (FBRT) Investors of Securities Class Action Deadline on April 27, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Franklin To Contact Him Directly To Discuss Their Options
Kyndryl Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Kyndryl Holdings, Inc. - KDNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in securities class action lawsuits against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (
NYSE: KD), if they purchased or otherwise acquired the Company’s shares between August 1, 2024 and February 9, 2026, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Eastern and Southern Districts of New York.
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNONEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2026 to file lead plaintiff applications in a securities class action lawsuit against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NasdaqCM: SLNO), if they purchased or otherwise acquired the Company’s shares between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options
Apollo Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Apollo Global Management, Inc. - APONEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 1, 2026 to file lead plaintiff applications in a securities class action lawsuit against Apollo Global Management, Inc. (
NYSE: APO) (“Apollo” or the “Company”), if they purchased or otherwise acquired the Company’s securities between May 10, 2021 and February 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
ENPH SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Enphase (ENPH) Investors of Securities Class Action Deadline on April 20, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Enphase To Contact Him Directly To Discuss Their Options
Navan Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Navan, Inc. - NAVNNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 24, 2026 to file lead plaintiff applications in a securities class action lawsuit against Navan, Inc. (“Navan” or the “Company”) (NasdaqGS: NAVN), if they purchased or otherwise acquired the Company’s shares pursuant and/or traceable to the Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with Navan’s October 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Northern District of California.
Enphase Energy Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Enphase Energy, Inc. - ENPHNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Enphase Energy, Inc. (“Enphase” or the “Company”) (NasdaqGM: ENPH), if they purchased or otherwise acquired the Company’s securities between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORTNEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) (“Corcept” or the “Company”), if they purchased or otherwise acquired the Company’s shares between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
DUOL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DuolingoFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Duolingo To Contact Him Directly To Discuss Their Options
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURENEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against uniQure N.V. (NasdaqGS: QURE) (“uniQure” or the “Company”), if they purchased or otherwise acquired the Company’s shares between September 24, 2025 and October 31, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
COTY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Coty (COTY) Investors of Securities Class Action Deadline on May 22, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Coty To Contact Him Directly To Discuss Their Options
KD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Kyndryl (KD) Investors of Securities Class Action Deadline on April 13, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kyndryl To Contact Him Directly To Discuss Their Options
RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In REGENXBIO To Contact Him Directly To Discuss Their Options
HELE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Helen of TroyFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy To Contact Him Directly To Discuss Their Options
LU SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Lufax (LU) Investors of Securities Class Action Deadline on May 20, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lufax To Contact Him Directly To Discuss Their Options
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARENEW ORLEANS, April 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 6, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE), if they purchased or otherwise acquired the Company’s shares between August 3, 2023 and December 26, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
IBRX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds ImmunityBio (IBRX) Investors of Securities Class Action Deadline on May 26, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ImmunityBio To Contact Him Directly To Discuss Their Options
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him Directly To Discuss Their Options
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or “the Company”) (
NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options
PLUG SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Plug Power (PLUG) Investors of Securities Class Action Deadline on April 3, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Plug Power To Contact Him Directly To Discuss Their Options
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against REGENXBIO Inc. (“Regenxbio” or “the Company”) (
NASDAQ: RGNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
SMR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds NuScale (SMR) Investors of Securities Class Action Deadline on April 20, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NuScale To Contact Him Directly To Discuss Their Options
NKTR SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (
NASDAQ: RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mereo BioPharma Group plc (“Mereo” or “the Company”) (
NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PSFE Investors Have Opportunity to Lead Paysafe Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paysafe Limited (“Paysafe” or “the Company”) (
NYSE: PSFE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (
NASDAQ: QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nutrition Capital Network Spring Investor Meeting: A Premier Showcase of Health & Wellness InnovationNEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Nutrition Capital Network (NCN) is thrilled to announce its highly anticipated Spring Investor Meeting, taking place on April 16, 2026, at Chelsea Industrial in New York City. This exclusive event will bring together investors, corporate entrepreneurs, and industry leaders to explore cutting-edge innovations in the health and wellness space, fostering connections that drive growth and investment opportunities.
MNDY SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds monday.com (MNDY) Investors of Securities Class Action Deadline on May 11, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Monday.com To Contact Him Directly To Discuss Their Options
PMI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Picard Medical To Contact Him Directly To Discuss Their Options
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PSFE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Paysafe Limited (PSFE) Investors of Securities Class Action Deadline on April 7, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Paysafe To Contact Him Directly To Discuss Their Options
Simple, Convenient, Time-Saving Snacks for Busy FamiliesNEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) When every afternoon feels like a race to the dinner table and weekends are a blur of activities, there’s only one way to keep loved ones from getting “hangry”: easy, delicious appetizers and snacks. Keeping a few must-have ingredients in the pantry can help you avoid those dreaded moments between meals when stomachs are growling and a meal feels so close, yet so far away.
PYPL SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds PayPal (PYPL) Investors of Securities Class Action Deadline on April 20, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PayPal To Contact Him Directly To Discuss Their Options
Beacon Hill Appoints Tim Barber to Lead Finance & Accounting in CharlotteCharlotte, NC, April 02, 2026 (GLOBE NEWSWIRE) -- Beacon Hill announced today that Tim Barber has been named Division Director, Beacon Hill Financial, leading the firm’s Finance & Accounting practice in the Charlotte, North Carolina market.
Circana Names Hélène Bouffard Chief People Officer as Company Elevates Its AI and Talent AgendaChicago, April 02, 2026 (GLOBE NEWSWIRE) -- Circana LLC today announced that Hélène Bouffard has been appointed Chief People Officer, where she will lead the company’s global people strategy and guide organizational evolution during a period of accelerated growth and increasing AI adoption.
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives NationwidePOMPANO BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced significant reimbursement milestones for its Freedom® Peripheral Nerve Stimulator (PNS) System, expanding access to a clinically validated, permanent non-opioid treatment option for chronic pain management.
Blending Digital Tools with Expert Support Drives Greater Retirement PreparednessTruStage® survey shows confidence rises when participants use digital planning tools and personalized guidance emphasizing an industry shift toward multi-format education
KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kyndryl Holdings, Inc. (“Kyndryl” or “the Company”) (
NYSE: KD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GeneProof Announces CMV IVDR Launch on the myCROBE™ Fully Automated System for Transplant CareBrno, Czechia, April 02, 2026 (GLOBE NEWSWIRE) -- GeneProof, a molecular diagnostics manufacturer and part of NuvinkaDx, announced several significant product and regulatory milestones.
PLUG Investors Have Opportunity to Lead Plug Power Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Plug Power Inc. (“Plug Power” or “the Company”) (
NASDAQ: PLUG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Behind the World’s Fastest Growth: OMODA & JAECOO Unveil Third-Anniversary Achievements at the Beijing Auto ShowWUHU, China, April 02, 2026 (GLOBE NEWSWIRE) -- The global automotive industry is undergoing profound transformation, with the worldwide wave of vehicle intelligence and new energy reshaping the market landscape. In this high-stakes race, OMODA & JAECOO—brands under the Chery Group—have charted a growth trajectory that has captured the industry’s attention: in less than three years, they have gone from zero to over 900,000 vehicles sold and expanded from a single market to 64 markets, creating an unprecedented growth miracle for a global automotive brand. In April 2026, during the Beijing Auto Show, this brand—renowned for its “new speed”—will hit the dual milestones of its third anniversary and one million units sold.
Magnum® and Celebrity Nail Artist Naomi Yasuda Transform the Iconic Magnum Ice Cream Bar into a Limited-Edition Nail CollectionInspired by Magnum’s signature chocolate-dipped bars, the exclusive, handcrafted press-on nail set will be available for fans nationwide to shop just in time for festival season
IP Strategy Publishes Monthly Validator UpdateMonthly release covers the period from March 1-31, 2026
RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Richtech Robotics Inc. (“Richtech” or “the Company”) (
NASDAQ: RR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 02, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oracle Corporation (“Oracle” or “the Company”) (
NYSE: ORCL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
